MedPath
HSA Approval

AMLOPIN TABLET 5MG

SIN15498P

AMLOPIN TABLET 5MG

AMLOPIN TABLET 5MG

May 28, 2018

PAN-MALAYAN PHARMACEUTICALS PTE LTD

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPAN-MALAYAN PHARMACEUTICALS PTE LTD
Licence HolderPAN-MALAYAN PHARMACEUTICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Intas Pharmaceuticals Limited

Active Ingredients

Amlodipine besylate 6.950mg equiv to Amlodipine

5mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMLOPIN TABLET 5MG - HSA Approval | MedPath